ALSO NOTED: Flu vaccines a bust; New rabies vaccine developed for developing countries; and much more...

Vaccine Market

It's official. This year's flu season turned out to be the worst in four years, largely because the vaccine in use didn't work against the strains in circulation. The flu season probably peaked in mid-February. Report

A bond program used to finance vaccines for the world's poorest people has served as a model for other such initiatives in developing countries. Story

Schering-Plough sold a lineup of animal vaccines to Pfizer and France's Virbac. The deal was required by European regulators for their approval of Schering-Plough's acquisition of the animal health business of Akzo Nobel N.V. Report

UK officials say a national immunization program has prevented any deaths in children under the age of 19 from group C meningitis. Dawn Primarolo, public health minister, said: "This report underlines the need for vaccination and proves that our program is helping to halt diseases in their tracks." Report

Travelers in the U.S. face periodic shortages of yellow fever vaccine. Story

Biovet, an integrated biotechnology firm, on Wednesday launched Asia's first Bio Safety Level-4 manufacturing facility, specifically designed to enable product development and manufacturing of vaccines like Foot and Mouth Disease vaccine. Story

Novartis Vaccines & Diagnostics Inc and Aventis Pharma are moving closer to resolving a dispute over marketing an anti-rabies vaccine in South Asia. Report

Vaccine Research

A group of researchers at Oxford have developed a less expensive rabies vaccine for use in developing countries. Report

A research collaboration project between Mahidol University's Siriraj Hospital, Thammasat University's Faculty of Allied Health Science, Kasetsart University and Thailand Research Fund is targeting development of a new universal vaccine to fight a bid flu pandemic. Report

A team of American and Canadian officials updated health officials on breakthrough work on a vaccine to harness the lethal Ebola virus. Story

Vietnam has kicked off a new human trial of a bird flu vaccine developed in the country to fight a human outbreak. Report

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.